Related Experiment Video
Updated: Jun 18, 2026

Directed Cellular Self-Assembly to Fabricate Cell-Derived Tissue Rings for Biomechanical Analysis and Tissue Engineering
Published on: November 25, 2011
Current biofabrication methods for vascular tissue engineering and an introduction to biological textiles
Fabien Kawecki1, Nicolas L'Heureux1
1Univ. Bordeaux, INSERM, BIOTIS, UMR1026, Bordeaux, F-33000, France.
Insights
Tissue-engineered vascular grafts (TEVGs) offer a promising solution for small-diameter vessel repair, addressing limitations of synthetic and autologous options. Textile-inspired biofabrication methods accelerate production and enhance control over graft properties.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Vascular Surgery
Background:
- Cardiovascular diseases, including atherosclerosis, are a major global cause of death.
- Current synthetic vascular grafts have poor outcomes in small-diameter applications (< 6 mm).
- Autologous vessels are limited in availability and quality for small vessel repair.
Purpose of the Study:
- To review current scaffold-based and scaffold-free approaches for biofabricating tissue-engineered vascular grafts (TEVGs).
- To introduce biological textile approaches for TEVG development.
- To highlight advantages of textile-inspired methods in TEVG production.
Main Methods:
- Overview of scaffold-based tissue engineering for TEVGs.
- Overview of scaffold-free tissue engineering for TEVGs.
- Introduction to biological textile assembly methods for TEVGs.
Main Results:
- Textile-inspired approaches reduce production time compared to traditional bioreactor methods.
- These methods offer improved directional and regional control over TEVG mechanical properties.
- TEVGs aim to provide native-like mechanical and biological properties for small-diameter applications.
Conclusions:
- There is a significant clinical need for effective small-diameter vascular grafts.
- Tissue-engineering, particularly textile-inspired approaches, shows potential for overcoming limitations of current grafts.
- Further development of TEVGs is crucial for improving cardiovascular disease treatment outcomes.
Abstract:
Cardiovascular diseases are the leading cause of mortality in the world and encompass several important pathologies, including atherosclerosis. In the cases of severe vessel occlusion, surgical intervention using bypass grafts may be required. Synthetic vascular grafts provide poor patency for small-diameter applications (< 6 mm) but are widely used for hemodialysis access and, with success, larger vessel repairs. In very small vessels, such as coronary arteries, synthetics outcomes are unacceptable, leading to the exclusive use of autologous (native) vessels despite their limited availability and, sometimes, quality. Consequently, there is a clear clinical need for a small-diameter vascular graft that can provide outcomes similar to native vessels. Many tissue-engineering approaches have been developed to offer native-like tissues with the appropriate mechanical and biological properties in order to overcome the limitations of synthetic and autologous grafts. This review overviews current scaffold-based and scaffold-free approaches developed to biofabricate tissue-engineered vascular grafts (TEVGs) with an introduction to the biological textile approaches. Indeed, these assembly methods show a reduced production time compared to processes that require long bioreactor-based maturation steps. Another advantage of the textile-inspired approaches is that they can provide better directional and regional control of the TEVG mechanical properties.

